EMA approves Pfizer and Moderna Covid-19 booster shots
The European Medicines Agency recommends that immunocompromised people receive a third dose of one of the coronavirus vaccines, and states that a third Pfizer jab should be considered for all adults.
BY RITZAU, TRANSLATED BY CATHERINE BRETT
People with a significantly compromised immune system should receive a third dose – also called a booster shot – of the Covid-19 vaccine developed by Pfizer/BioNTech or Moderna, the European Medicines Agency (EMA) states.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk Foundation to boost pandemic prevention
For subscribers
Janssen is foreign company of the year in Denmark
For subscribers
Sanofi pivots toward boosters after Covid vaccine delays
For subscribers
.jpg&w=384&q=75)
